Aminosyn II 4.25
"The U.S. Food and Drug Administration and the U.S. Environmental Protection Agency today issued draft updated advice on fish consumption. The two agencies have concluded pregnant and breastfeeding women, those who might become pregnant, and young"...
Aminosyn II 4.25% in 25% Dextrose
Aminosyn II 4.25 Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Aminosyn II 4.25% in 25% Dextrose Injection (amino acids) is a combination of amino acids used for central vein infusion in the prevention of nitrogen loss and negative nitrogen balance in cases where (a) the gastrointestinal tract by the oral, gastrostomy or jejunostomy route cannot or should not be used, (b) gastrointestinal absorption of nutrients is impaired or (c) metabolic requirements for protein and calories are substantially increased as with extensive burns and (d) morbidity and mortality may be reduced by replacing amino acids lost from tissue breakdown, thereby preserving tissue reserves, as in acute renal failure. Common side effects include skin redness, inflammation, and swelling, or infection at the injection site. Flushing, fever, and nausea may also occur.
The total daily dose of Aminosyn II 4.25% Injection to be infused depends on daily protein and caloric requirements and on the patient's metabolic and clinical response. Aminosyn II 4.25% may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Aminosyn II 4.25% should be used only if prescribed. Consult your doctor before breastfeeding.
Our Aminosyn II 4.25% in 25% Dextrose Injection (amino acids) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Aminosyn II 4.25 FDA Prescribing Information: Side Effects
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Read the entire FDA prescribing information for Aminosyn II 4.25 (Amino Acid Injection in Dextrose Injection)
Additional Aminosyn II 4.25% in 25% Dextrose Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Weight Loss Wisdom
Get tips, recipes and inspiration.